Group Prior Approval

This page is in the process of being updated with accessible versions of the Group Prior Approvals. If you are unable to find the form you require, please email cpicb.prescribingpartnership@nhs.net to request a copy.

Dermatology

Adalimumab for Severe Localised Psoriasis in Adults - Local Agreement

TA103, 134, 146 Biologics for Plaque Psoriasis in Adults

TA177 Alitretinoin for the treatment of severe chronic hand eczema

TA339 Omalizumab 

TA350 Secukinumab for Plaque Psoriasis in Adults

TA475 Dimethyl fumerate for the treatment of moderate to severe plaque psoriasis in adults

TA511 Brodalumab in severe plaque psoriasis

TA534 Dupilumab for Atopic Dermatitis in Adults

TA574 Certolizumab for severe plaque psoriasis in adults

TA575 Tildrakizumab for severe plaque psoriasis in adults

TA907 Deucravacitinib for Plaque Psoriasis in Adults

Endocrinology

CamAPS FX for Adults and Children with Approved Funding for IPT - Local Agreement

Continuous Glucose Monitoring in Adults over 19 yrs - Local Agreement

Continuous Glucose Monitoring For Children and Young People Under 19yrs - Local Agreement

Medtronic EWIS 7-day Infusion Set - Local Agreement

Omnipod 5 Closed Loop System NICE TA151 and Local Agreement

TA151 Continuous Subcutaneous Insulin Infusion Therapy for Type I Diabetes Mellitus

TA863 Somatrogon for Growth Distrubance in Children and Adolescents Over 3yrs

Gastroenterology

Haematology

Rituximab Biosimilar For Idiopathic Thrombocytopenic Purpura in Adults – Local Agreement

Rituximab Biosimilar For The Initial Treatment of Autoimmune Haemolytic Anaemia in Adults – Local Policy

Rituximab Biosimilar for The Initial Treatment of Thrombotic Thrombocytopenic Purpura in Adults - Local Agreement

TA221 Romiplostim for Chronic Immune Thrombocytopenia in Adults

TA617 Lusutrombopag for severe thrombocytopenia prior to surgery in adults with liver disease

TA626 Avatrombopag for severe thrombocytopenia prior to surgery in adults with liver disease

TA697 Andexanet Alfa for Uncontrolled or Life-Threatening GI Bleeding in Adults on Apixaban or Rivaroxaban Treatment

TA853 Avatrombopag for Primary Chronic Immune Thrombocytopenia in Adults

PegInterferon Alfa-2a for Essential Thrombocythaemia Polycythaemia Vera or Myelofibrosis in Adults - Local Agreement

Miscellaneous

Budesonide for Immunglobulin A Nephropathy (IgAN) in Adults [docx] 669KB

Liothyronine Sodium 20mcg Inj for thyrotoxic crisis - Local Agreement

TA358 Tolvaptan for treating autosomal dominant polycystic kidney disease in Adults

TA393 Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia

TA394 Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia

Neurology

MTG46 gammaCore for cluster headache accessible

TA659 Galcanezumab for Chronic Migraine in Adults

TA659 Galcanezumab for Episodic Migraine in Adults

TA758 Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy

TA764 Fremanezumab for Chronic Migraine in Adults

TA764 Fremanezumab for Episodic Migraine in Adults

TA862 Erenumab for Chronic Migraine in Adults

TA862 Erenumab for Episodic Migraine in Adults

TA871 Eptinezumab for Chronic Migraine in Adults

TA871 Eptinezumab for Episodic Migraine in Adults 

TA906 Rimegepant for Episodic Migraine in Adults

Orthopaedics

Exogen Bone Healing System for NU long bone fractures - Local Agreement

Respiratory

TA878 Tocilizumab for Covid-19 in Adults

Rheumatology

Abatacept Monotherapy for Rheumatoid Arthritis in Adults - Local Agreement

Infliximab for Patients with Juvenile Idiopathic Arthritis Transferring to Adult Services - Local Agreement

Rituximab Biosimilar for Early Rheumatoid Arthritis in Adults - Local Policy

TA175 Infliximab Biosimilar for Moderate Rheumatoid Arthritis in Adults

TA195, 247, 375, 485 Biologics with Methotrexate (Form A) for Rheumatoid Arthritis in Adults accessible

TA195, 375 and 485 Biologics for Rheumatoid Arthritis in Adults Monotherapy (Form B)

TA199 and 220 Biologics for Psoriatic Arthritis in Adults

TA340 Ustekinumab for Psoriatic Arthritis in Adults

TA373 Biologics in Juvenile Idiopathic Arthritis

TA383 and 497 Biologics for Ankylosing Spondilitis and Axial Spondyloarthritis in Adults

TA433 Apremilast for psoriatic arthritis in Adults

TA445 Certolizumab and Secukinumab for Active Psoriatic Arthritis in Adults

TA466 Baricinib for Rheumatoid Arthritis in Adults

TA537 - Ixekizumab for psoriatic arthritis

TA543 Tofacitinib for Psoriatic Arthritis in Adults

TA718 Ixekizumab for Ankylosing Spondylitis in Adults

TA719 Secukinumab for Axial Spondyloarthritis in Adults

TA768 Upadacitinib for PsA in Adults

TA861 Upadacitinib for Non-Radiographic Axial Spondyloarthritis in Adults

TA916 Bimekizumab for Psoriatic Arthritis in Adults

TA918 Bimekizumab for Axial Spondyloarthritis in Adults

TA920 Tofacitinib for Ankylosing Spondylitis in Adults